garlic & health a european initiative for the development of high quality garlic and its...
TRANSCRIPT
Garlic & Health
a European initiative for the development
of high quality garlic and its influence on
biomarkers of atherosclerosis and cancer
in humans for disease prevention
Chris Kik, Plant Research International, Wageningen, The
Netherlands
Garlic & Health: project key facts
started in February 2000 running time: 4 years budget: 6.112.384 Euro (EU: 3.939.136
Euro) 14 partners: 6 universities, 6 research
institutes, 2 companies (and 5 subcontractors)
countries involved: FR (4), GER (3), UK (2), NL (2), ISR (2) and ESP (1)
human resources: 84 person years input
W P 4: S u lp h ur p a th w ay
W P 3 : C u lt iva tion
W P 2: B ree d in g S yste m s
W P 1 :G e n e tic R e so u rces
G a rlic th e m eco o rd in a to r
W P 8: H um a n in te rven tion
W P 7 : P h arm a ce u tics
W P 6 : C a n cer
W P 5 : C a rd io -va scu la r d ise a ses
H e a lth the m eco o rd in a to r
G e n era l P ro jec t coo rd in a to r
Garlic & Health: management structure
Every WP has a coordinator which co-ordinates the activities of the participants involved
Garlic & Health: communication
Good communication is one of the most important factors for the success of a project
Garlic & Health: communication
Meetings half year: 1.5 days; annual: 3 days; ad hoc
Internet home page: public and restricted area monthly e-reports
Presentations scientific: articles, posters, etc popular: newspapers, brochures, etc
Garlic & Health: communication
Confidentiality contract consortium agreement
‘No info goes unauthorized to other parties outside the project’
Garlic & Health: rationale behind the
project
Garlic: quality and price of European garlic is not competitive on the world (and European) market
Health: lack of studies on the precise action of garlic in the prevention of cardio-vascular diseases and cancer
Garlic & Health: main project aim
‘To improve the quality of garlic and derived products and to understand the sulphur metabolism in the plant as well as in the human body, in order to strengthen the European based garlic pharma and food industry and to increase public health’
Garlic & Health: garlic research foci
WP1: Genetic resources Establishment of a unique garlic core collection (sulphur,
fertility) WP 2: Breeding systems
Sexual hybridization, genetic transformation, mass propagation
WP 3 : Cultivation methods WP 4: Analysis of the sulphur pathway in garlic
S pathway intermediates S genes localization of S pathway in plant
Sulphur metabolism in plants
SOIL
SO42-
sulfatetransporters
SO42- APS SO3
2-
sulfite reductase
ATP PPi2e-
ATP sulfurylase
6e-
APS reductase
S2-
serine +acetyl CoA
serine acetyltransferase
OAScysteine synthetase
CYS-glutamylcysteine synthetase
-glu-
CYS
glu
glutathioneGSH synthetase
gly
METHIONINE
Stress, secondary
metabolism
Allium - specific sulphur metabolism
glutathione
methyl
S-me-GSHglu
-glu-me-cysOxidase [under characterization]
-glu-me-cys sulfoxide-glutamyl transpeptidase[cloned]
methyl-cysteine sulfoxide
?
Allium &crucifers
Allium onlyMethacrylate
carboxy-propyl-GSH
-glu-carboxypropyl-cysteine
propyl & propenyl cysteine sulfoxide
?
?
Garlic & Health: health research foci
WP 5 and 6: Analysis of the molecular mechanisms of garlic bio-active sulphur compounds in cardio-vascular diseases and cancer
WP 7: Establishment of pharmaceutical requirements for new garlic formulations
WP 8: Testing of newly developed formulations in a human intervention study
{
media
intima
fibrosischolesterol
clefts necrosis
mineralisation
Atherosclerosis in aorta of APOE*3-Leiden transgenic mice
Normal cell Tumoral cellsInitiated cell
Programmed death of damaged cells(APOPTOSIS)
DNA mutation Proliferation
Normal cells
Repair
Garlic & Health: carcinogenesis
Conversion
Preneoplastic foci induced by aflatoxin B1 in the rat liver
Control diet Diallyl disulfide (2000 ppm in the diet)
Garlic & Health: pharmaceutics
Development of analytical and dissolution methods
Development of new garlic dosage forms bio-availability stability
Garlic & Health: human intervention
study placebo controlled three months study
with 2 x 24 volunteers check on biomarkers for:
atheroclerosis: ox-LDL, adhesion molecules, etc cancer: phase II enzymes, damage to
lymphocytes, etc